5 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners

4. United Therapeutics Corporation (NASDAQ:UTHR)

Parkman Healthcare Partners’ Stake Value: $17,410,000

Percentage of Parkman Healthcare Partners’ 13F Portfolio: 4.40%

Number of Hedge Fund Holders: 52

United Therapeutics Corporation (NASDAQ:UTHR) disclosed Q3 results on November 3. EPS for the period amounted to $4.16, beating estimates by $0.07. The quarterly revenue equaled $444.70 million, jumping 17% on a year-over-year basis, and exceeding estimates by $23.25 million. United Therapeutics Corporation (NASDAQ:UTHR) is a biotech company focused on creating life-enhancing technologies for patients with lung diseases and for those individuals in need of organ manufacturing.

Greg Martinez, via Parkman Healthcare Partners, holds 94,324 shares in United Therapeutics Corporation (NASDAQ:UTHR), worth $17.41 million, representing 4.4% of the firm’s Q3 portfolio. Jim Simons’ Renaissance Technologies is the leading United Therapeutics Corporation (NASDAQ:UTHR) stakeholder, owning over 3 million shares worth $559 million. 

Insider Monkey tracks the movement of 867 hedge funds as of Q3 2021, of which 52 funds were bullish on United Therapeutics Corporation (NASDAQ:UTHR), with stakes worth $2.17 billion. This is comparable to 45 funds in the preceding quarter, with a total stake value of $2.33 billion.